The Seki lab also recently reported that tlr2−/− mice are protected from progression of CDAA-induced NASH to fibrosis and they suggested this was due to an impaired inflammatory reaction associated with reduced expression of NLRP3 inflammasome components [23]. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.